 |
2 Products |  |
47 Diseases | | 2 Products |
|
5 Trials |  |
424 News |  |
| «1234 |
- ||| piclidenoson (CF101) - Can / Fite, Cipher, China Medical System
Enrollment change: Safety and Efficacy Study of CF101 to Treat Psoriasis (clinicaltrials.gov) - Sep 22, 2011
P2, N=76, Completed, Sponsor: Can-Fite BioPharma
N=60 --> 76
- | namodenoson (CF102) - Can / Fite
Enrollment closed, Metastases: A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma (clinicaltrials.gov) - Aug 17, 2011
P1/2, N=20, Active, not recruiting, Sponsor: Can-Fite BioPharma
N=60 --> 76 Recruiting --> Active, not recruiting
- | namodenoson (CF102) - Can / Fite
Trial completion: A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 (clinicaltrials.gov) - Aug 17, 2011
P1/2, N=32, Completed, Sponsor: Can-Fite BioPharma
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| piclidenoson (CF101) - Can / Fite, Cipher, China Medical System
Enrollment change: Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca (clinicaltrials.gov) - Aug 10, 2011
P2, N=80, Completed, Sponsor: Can-Fite BioPharma
Recruiting --> Completed N=50 --> 80